Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A physician-reviewed guide to rare but serious adverse events linked to Rezdiffra (resmetirom), covering hepatotoxicity signals, drug interactions, FAERS data, and the MAESTRO-NASH trial safety profile.
Read clinical reviewA comprehensive, citation-dense breakdown of Rezdiffra (resmetirom) adverse events from MAESTRO-NASH, MAESTRO-NAFLD-1, FAERS reports, and the FDA prescribing label, with exact incidence rates by dose and trial arm.
Read clinical reviewA comprehensive clinical review of Rezdiffra (resmetirom) side effects, including potentially permanent adverse events, hepatic risks, trial data from MAESTRO-NASH, FDA labeling, and post-market surveillance findings.
Read clinical reviewA comprehensive clinical breakdown of Rezdiffra (resmetirom) adverse events by severity grade and patient phenotype, drawing on MAESTRO-NASH, FAERS data, and the FDA prescribing label.
Read clinical review